Pulse of the industry: Driving medtech growth by innovating business models

Medtech businesses are still feeling the impacts of the COVID-19 crisis and looking for ways to respond. Our research suggests that many have identified business model innovation as a solution to the challenges they face and a potential engine for growth in the sector.

After more than two years navigating the COVID-19 health crisis, the medtech industry is still suffering from some of its biggest effects: inflation, supply chain disruption, and budget limitations. However, most companies have managed to leverage an increase in demand and have emerged from the pandemic just as competitive as when it began.

Medtech firms haven’t simply settled for strengthening their existing business models, though. Instead, many are innovating entirely new business models for the post-COVID-19 era. Our survey of 60 major medtech players across the US and Europe shows that four out of every five companies have identified business model innovation as crucial to securing their medium-…